These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36815689)

  • 1. Risk factors for impaired respiratory function post COVID-19: A prospective cohort study of nonhospitalized and hospitalized patients.
    Björsell T; Sundh J; Lange A; Ahlm C; Forsell MNE; Tevell S; Blomberg A; Edin A; Normark J; Cajander S
    J Intern Med; 2023 May; 293(5):600-614. PubMed ID: 36815689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge.
    Sibila O; Perea L; Albacar N; Moisés J; Cruz T; Mendoza N; Solarat B; Lledó G; Espinosa G; Barberà JA; Badia JR; Agustí A; Sellarés J; Faner R
    Respir Res; 2022 Feb; 23(1):37. PubMed ID: 35189887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge.
    Bellan M; Soddu D; Balbo PE; Baricich A; Zeppegno P; Avanzi GC; Baldon G; Bartolomei G; Battaglia M; Battistini S; Binda V; Borg M; Cantaluppi V; Castello LM; Clivati E; Cisari C; Costanzo M; Croce A; Cuneo D; De Benedittis C; De Vecchi S; Feggi A; Gai M; Gambaro E; Gattoni E; Gramaglia C; Grisafi L; Guerriero C; Hayden E; Jona A; Invernizzi M; Lorenzini L; Loreti L; Martelli M; Marzullo P; Matino E; Panero A; Parachini E; Patrucco F; Patti G; Pirovano A; Prosperini P; Quaglino R; Rigamonti C; Sainaghi PP; Vecchi C; Zecca E; Pirisi M
    JAMA Netw Open; 2021 Jan; 4(1):e2036142. PubMed ID: 33502487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between exercise capacity and fatigue, dyspnea, and lung function in non-hospitalized patients with long COVID.
    Njøten KL; Espehaug B; Magnussen LH; Jürgensen M; Kvale G; Søfteland E; Aarli BB; Frisk B
    Physiol Rep; 2023 Nov; 11(22):e15850. PubMed ID: 37984816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
    Wu X; Liu X; Zhou Y; Yu H; Li R; Zhan Q; Ni F; Fang S; Lu Y; Ding X; Liu H; Ewing RM; Jones MG; Hu Y; Nie H; Wang Y
    Lancet Respir Med; 2021 Jul; 9(7):747-754. PubMed ID: 33964245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of Diffusion Capacity Impairment and Its Relationship with Dyspnea 12 Months after Hospitalization for COVID-19.
    Kang A; Regmi B; Cornelissen C; Smith J; Daher A; Dreher M; Spiesshoefer J
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592095
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical predictors of lung function in patients recovering from mild COVID-19.
    Cortes-Telles A; Figueroa-Hurtado E; Ortiz-Farias DL; Zavorsky GS
    BMC Pulm Med; 2022 Jul; 22(1):294. PubMed ID: 35909118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 pneumonia.
    Orzes N; Pini L; Levi G; Uccelli S; Cettolo F; Tantucci C
    Respir Med; 2021 Sep; 186():106541. PubMed ID: 34280885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up study.
    Scaramuzzo G; Ronzoni L; Campo G; Priani P; Arena C; La Rosa R; Turrini C; Volta CA; Papi A; Spadaro S; Contoli M
    BMC Pulm Med; 2022 Nov; 22(1):408. PubMed ID: 36352423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection.
    Chun HJ; Coutavas E; Pine AB; Lee AI; Yu VL; Shallow MK; Giovacchini CX; Mathews AM; Stephenson B; Que LG; Lee PJ; Kraft BD
    JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34111030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort.
    Ribeiro Baptista B; d'Humières T; Schlemmer F; Bendib I; Justeau G; Al-Assaad L; Hachem M; Codiat R; Bardel B; Abou Chakra L; Belmondo T; Audureau E; Hue S; Mekontso-Dessap A; Derumeaux G; Boyer L
    Respir Res; 2022 Mar; 23(1):68. PubMed ID: 35317815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent
    Matheson AM; McIntosh MJ; Kooner HK; Lee J; Desaigoudar V; Bier E; Driehuys B; Svenningsen S; Santyr GE; Kirby M; Albert MS; Shepelytskyi Y; Grynko V; Ouriadov A; Abdelrazek M; Dhaliwal I; Nicholson JM; Parraga G
    Radiology; 2022 Nov; 305(2):466-476. PubMed ID: 35762891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of post-COVID-19 infection pulmonary functions in healthcare professionals.
    Gülhan PY; Arbak PM; Annakkaya AN; Balbay EG; Balbay ÖA
    Am J Infect Control; 2022 Oct; 50(10):1125-1132. PubMed ID: 35870662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome.
    Fortini A; Rosso A; Cecchini P; Torrigiani A; Lo Forte A; Carrai P; Alessi C; Fabbrizzi F; Lovicu E; Sbaragli S; Faraone A
    Infection; 2022 Apr; 50(2):513-517. PubMed ID: 35061232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary function and Quality of Life in a prospective cohort of (non-) hospitalized COVID-19 pneumonia survivors up to six months.
    de Roos MP; Siegerink S; Dijkstra NG; Broekman BF; Brinkman K; Jonkman NH; Bresser P
    Chron Respir Dis; 2022; 19():14799731221114271. PubMed ID: 36367295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial.
    Bazdyrev E; Panova M; Brachs M; Smolyarchuk E; Tsygankova D; Gofman L; Abdyusheva Y; Novikov F
    J Transl Med; 2022 Nov; 20(1):506. PubMed ID: 36329513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea.
    Cortés-Telles A; López-Romero S; Figueroa-Hurtado E; Pou-Aguilar YN; Wong AW; Milne KM; Ryerson CJ; Guenette JA
    Respir Physiol Neurobiol; 2021 Jun; 288():103644. PubMed ID: 33647535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serum ferritin level and decreased diffusion capacity 3 months after the onset of COVID-19 pneumonia.
    Shinfuku K; Takasaka N; Fukuda T; Chida K; Suzuki Y; Shibata S; Kojima A; Hasegawa T; Yamada M; Yamanaka Y; Hosaka Y; Seki A; Seki Y; Takeda H; Ishikawa T; Kuwano K
    PLoS One; 2023; 18(2):e0281249. PubMed ID: 36795727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for persistent tomographic abnormalities at 6 months of follow-up in a cohort of hospitalized patients with moderate and severe COVID-19 living at high altitude.
    Rincon-Alvarez E; Gonzalez-Garcia M; Ali-Munive A; Casas A; Proaños NJ; Giraldo-Cadavid LF; Moreno A; Pérez C; Rubiano W; Cogollo M; Parada-Tovar P; Torres-Duque CA
    Front Med (Lausanne); 2023; 10():1110535. PubMed ID: 36844204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.